central nervous system uptake of intranasal glutathione in parkinson's disease Sunday Morning with Laurie Mischley June 14, 2020 Frontiers | Intranasal delivery: An
Frontiers Intranasal delivery: An attractive route for the administration of nucleic acid based therapeutics for CNS disorders glutathione in parkinson's disease Enhanced accumulation of reduced glutathione by Scopoletin improves survivability of dopaminergic neurons in Parkinson's model Frontiers Crosstalk between neuroinflammation and ferroptosis: Implications for Parkinson's disease progression Nose to brain drug delivery: from bench to bedside PMC Glutathionea review on its role and significance in Parkinson's disease Martin 2009 The FASEB Journal Wiley Online Library Intranasal Nano Delivery Systems: Emerging Strategies for Central Nervous System Disease Therapeutics PMC
Pay in 4 interest-free payments of $5.34 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14





